Most Recent
Chemist Warehouse, Sigma win ACCC approval for $8.8B merger
The competition regulator has given its blessing to the $8.8 billion merger of Chemist Warehouse and Sigma Healthcare, subject to a promise that franchisees will be free to terminate their contracts.
Blackstone’s bid to acquire I’rom raises competition concerns over clinical trials
The ACCC has red flags about the acquisition of Japanese healthcare business I'rom Group by private equity behemoth Blackstone.
$405M pelvic mesh settlement distribution can’t ‘drag on’, judge says
A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
Class action over COVID-19 deaths settles with Anglicare, NSW Health
A class action over deaths allegedly caused by negligent care at a NSW aged care facility during COVID-19 has settled. 
‘Contingency on contingency’: Judge won’t halt IP dispute over Abilify generic
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
‘Highly irresponsible’: Peninsula Health must pay $316,000 in junior doctors class action
A judge has ordered Victoria's Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a “highly irresponsible attitude”.
Ninth junior doctors class action launched after courtroom victories
A ninth class action has been filed on behalf of junior doctors in Victoria who were allegedly underpaid for shift work, after two landmark wins in the Gordon Legal-led underpayments class actions.
Cipla attacks patent extension for Novo Nordisk weight loss drug
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
Government wants to stay 12-year-old dispute over Abilify generic
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
Medibank says Deloitte data breach report not relevant in shareholder class action
Medibank is seeking to shield from a shareholder class action an "irrelevant" post-incident report by Deloitte into its massive October 2022 data breach.